Suchergebnisse

COVID-19 has spread around the globe and infections are still rising despite the development of vaccinations and protocols. Various mutations of the SARS-CoV-2 virus have arisen with a greater rate of transmission and increased virulence. New found research has proven that the new strains of the virus are more virulent and use airborne aerosolized transmission to enable long range spread of the virus. By virtue of the fact that the virus spreads through such means, increases the risk of transmission and contamination highly as the virus can be transmitted via long range and through common ventilation and duct systems. In light of this it is now pertinent for legislation to support the use of personal protection equipment to safeguard the health of the public.

The Monkey pox virus is a member of the Orthopoxvirus genus in the family "Poxviridae". The Orthopoxvirus genus includes Monkey pox, Smallpox (variola virus), the vaccinia virus and the Cowpox virus. The first human case of Monkey pox was recorded in the 1970's in the (DRC) Democratic Republic of the Congo. Numerous cases of Monkey Pox have been reported to the WHO since the 1st of January 2022. As of the 15th of June 2022, a total of two thousand one hundred and three (2103) confirmed cases and 1 death have been registered by the WHO. Transmission of the Monkey Pox virus occurs through direct contact. Close contact such as that of skin to skin, mouth to mouth and face to face with the exposure to open lesions or lesions of the buccal mucosa aid the transmission of the disease. The virus is also transmitted through contaminated objects and materials ranging from pillows to bedding and the like. The occurrence and spread of this most recent outbreak of the virus has been mainly attributed to the sexual route of transmission. The sexual transmission predominantly occurring in men whom have had sexual relations with other men. Cases infected with Monkey Pox present with a high fever (pyrexia), vesicular and pustular rashes on the palms and soles and lymphadenopathy (lymphadenopathy being the main differentiating fever between Small Pox and Monkey Pox). Currently no licensed treatments are available for individuals infected with Monkey Pox, but brincidofovir and tecovirimat have shown promising use and efficacy against the virus in animals. The treatment is predominantly of the symptomatic type including paracetamol to combat the viral fever. Various medicaments can be used to prevent and control the Monkey Pox outbreak including (VIG) Vaccinia immunoglobulin, cidofovir and the Small Pox vaccine The current international outbreak of Monkey Pox, is by no means the next SARS-CoV-2 pandemic, however through stronger global surveillance and international collaboration the current up flaring of cases can be swiftly ...

The current global figures of COVID-19 is still rising. Many countries have enforced lockdowns to safeguard its citizens, however in most cases this has been to the dire detriment of the economy. Most leaders and governments have been holding out and looking to the development of a vaccine to be the answer to this COVID-19 pandemic, however at this point in time and for the foreseeable future a viable and widely available vaccine is not likely to be developed. In juxtaposition to the conventional methods countries such as Singapore, Israel, Iceland, Portugal, The Netherlands, Sweden, Hong Kong, Japan, South Korea, Indonesia, Taiwan and Turkey have adopted the concept of herd immunity. It is there for poignant and of the upmost importance that an alternate stratagem is developed and exercised to best facilitate the re-ignition of the country's economy as well to best protect its citizens from the virus. Models such as herd immunity or a model based thereon are the most logical solution to attain this goal. At this time in the development of the global COVID-19 pandemic it is too early to conclude as to whether a fully-fledged lockdown is more effective and useful than the establishment of herd immunity. In order to achieve the goal of safeguarding the lives of a countries citizens as well as its economy, a mixed method of lockdown and herd immunity is advised. Individuals who are economically active and less susceptible to the virus should adopt the herd immunity model, whereas those who are elderly with concomitant comorbidities should exercise self-isolation and follow the lockdown model. The application of using both models simultaneously, will both capitalize on the advantages of either and negate the drawbacks thereof. This ultimately decreasing the loss of lives whilst still inducing a degree of herd immunity within the general populous.

The SARS-CoV-2 virus which causes the disease termed COVID-19 ripped through the globe in the latter part of 2019 and has left a state of fear, death and destruction in its wake. The Omicron variant was officially announced by the South African authorities on the 24th of November 2021, with the first confirmed sample of the infection being collected on the 9th of November 2021. The initial cases were flagged as a possible new variant due to the stark differences in the presentation and clinical features of the patients. At the time of Omicron's discovery, the predominant variant circulating within South Africa was the Delta variant B.1.617.2 which typically presented with more severe and stark symptoms. Omicron spread rapidly within the Southern African content and abroad, principally South Africa, Botswana, Hongkong and Israel were among the first countries to record cases of the new variant. The first European case of the Omicron variant was confirmed on the 26th of November 2021 in Belgium. Towards the end of November 2021 cases of the new variant had been confirmed and recorded in France, the United Kingdom, Germany, Portugal and Scotland. Additional cases of the Omicron variant have been confirmed in Canada and Australia. At this current point in the development of the Omicron upsurge in cases the international community should aim for further vaccinations among their fellow countrymen, but more so vaccine equality should be ensured. Such equality should be ensured in the developing nations as the virus does not respect any boundaries or territories and thus a higher level of vaccination worldwide will confer greater protection to the global community as a whole.

The SARS-CoV-2 virus which causes the disease termed COVID-19 ripped through the globe in the latter part of 2019 and has left a state of fear, death and destruction in its wake. The Omicron variant was officially announced by the South African authorities on the 24th of November 2021, with the first confirmed sample of the infection being collected on the 9th of November 2021. The initial cases were flagged as a possible new variant due to the stark differences in the presentation and clinical features of the patients. At the time of Omicron's discovery, the predominant variant circulating within South Africa was the Delta variant B.1.617.2 which typically presented with more severe and distinct symptoms. Omicron spread rapidly within the Southern Africa and abroad, principally South Africa, Botswana, Hongkong and Israel were among the first countries to record cases of the new variant. The first European case of the Omicron variant was confirmed on the 26th of November 2021 in Belgium. Towards the end of November 2021 cases of the new variant had been confirmed and recorded in France, the United Kingdom, Germany, Portugal and Scotland. Additional cases of the Omicron variant have been confirmed in Canada, Australia, India and United States. At this current point in the development of the Omicron upsurge in cases the international community should aim for further vaccinations among their fellow countrymen, but more so vaccine equality should be ensured. Such equality should be ensured in the developing nations as the virus does not respect any boundaries or territories and thus a higher level of vaccination worldwide will confer greater protection to the global community as a whole.

Introduction: COVID-19 has spread across the entire planet, and multiple countries are experiencing their second and third wave of COVID-19 infections. The study's objective is to determine the approaches and methods implemented by Mauritius to control the transmission of COVID-19, which resulted in the flattening of the curve. Methods: A systematic search was undertaken using Pubmed, Pubmed Central, Embase, Trip, Google Scholar databases and the COVID-19 statistics-ministry of health and wellness, Mauritius, from January 15, 2020, to June 02, 2020. Results: As soon as case 0 was confirmed on March 18, 2020, contact tracing began. Within four days, the country went into a complete sanitary lockdown. A series of measures including legal legislation, general hygiene and sanitary protocols were issued by the government. International borders were closed. The 11th of May 2020 marked a great victory for the Republic of Mauritius as 335 patients had completely recovered, and only ten deaths were recorded. Conclusion: The most important strategy employed was the implementation of an early and stringent lockdown. The measures are taken by the government, its implementation and the adherence of the population to these measures played a more significant role in controlling the outbreak.